CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship

Esophageal Cancer Newsletter

TraceyS

Stay Current With Esophageal Cancer Treatment Advances & Connect with Others

CancerConnect Esophageal Cancer Newsletter

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Esophageal Cancer. These are available in our monthly Esophageal Cancer newsletter.

Stay Current - Connect With Other Esophageal Cancer Patients

Join The CancerConnect Community: Connect with others and receive regular updates

or

Sign up for the Esophageal Cancer Newsletter Here

Comments

Esophageal

FEATURED
COMMUNITY

Esophageal Cancer Survival Improved Using Precision Cancer Medicines

Genomic testing for EGFR HER2 and other cancer driving mutations and key biomarkers can help determine optimal treatment

Cancer Connect

Treatment & Management of Esophageal Cancer

Overview of treatment and for esophageal cancer

Cancer Connect

Checkpoint Inhibitors Improve Treatment of Esophageal Cancer

Checkpoint Inhibitors Opdivo and Keytruda improve survival and delay esophageal cancer recurrence

Cancer Connect

Treatment of Stage II - III Esophageal Cancer

Surgery, radiation chemotherapy, and precision cancer medicines may be part of stage II - III esophageal cancer treament

Cancer Connect

Surgical Treatment and Endoscopic Mucosal Resection for Esophageal Cancer

Surgeon experience, hospital volume and minimally invasive surgical techniques all contribute to improving outcomes.

Cancer Connect

Esophageal Cancer: 10 Tips on How to Get The Most From Your Doctor

In addition to going to a high volume treatment center here are 10 tips for facing esophogeal cancer.

Cancer Connect

Treatment of Stage IV of Esophageal Cancer

Treatment of stage IV esophageal cancer;

Cancer Connect

Treatment of Recurrent Esophageal Cancer

Understand treatment options for recurrent esophageal cancer and the role of clinical trials

Cancer Connect

Overview of Esophageal Cancer

Signs, Symptoms of Esophageal Cancer: Who's at risk? How is it diagnosed?

Cancer Connect

FDA Approves Cyramza™ in Combination With Paclitaxel for Esophageal Cancer

Cyramza™ in Combination With Paclitaxel for Gastroesophageal Junction Adenocarcinoma

Cancer Connect